Coverage
-
December 21, 2016
Attorneys representing a certified class in a long-running multidistrict litigation against Pfizer Inc. got everything on their Christmas list Wednesday when a New York federal judge gave final approval to a $468 million settlement and approved more than $150 million in attorneys' fees and litigation expenses.
8 other articles on this case.
View all »